Medicare Part D Formulary Coverage of Disease-Modifying Therapies for Multiple Sclerosis

Key Points

• This study aims to evaluate the coverage of disease-modifying therapies for multiple sclerosis under Medicare Part D, focusing on brand-name versus generic options.
• Cohort study analyzing formulary coverage under Medicare Part D for patients with multiple sclerosis.
• Comparison of coverage between brand-name and generic disease-modifying therapies.
• Identified significant differences in coverage between brand-name and generic drugs for multiple sclerosis therapies.
• Showed variability in formulary access that could impact patient treatment choices.